CJC-1295 No DAC + Ipamorelin Blend (10mg Total)
Synergistic GH Secretagogue Complex
$75.00$55.00
Grade: Research Grade / Analytical Standard
Purity: ≥99% Total Peptide Purity (HPLC Verified)
Format: Lyophilized (Freeze-Dried) Powder
Unit Size: 10 mg Total (CJC-1295 No DAC 5 mg / Ipamorelin 5 mg)
Product Overview
The CJC-1295 No DAC + Ipamorelin Research Blend is a dual-action secretagogue complex engineered for advanced laboratory investigation into pulsatile growth hormone (GH) release and somatotropic signaling. By combining CJC-1295 No DAC (Mod GRF 1-29, a growth hormone-releasing hormone / GHRH analogue) with Ipamorelin (a selective ghrelin receptor agonist / GHRP), this formulation reproduces natural physiological pulse amplification by targeting two distinct receptor pathways on pituitary somatotrophs.
Co-lyophilized at an optimal 1:1 ratio (5mg : 5mg), this blend eliminates multi-vial co-reconstitution errors, providing research facilities with a standardized matrix to study synergistic GH and IGF-1 axis upregulation without secondary elevation of cortisol or prolactin.
Key Research Features & Highlights
Dual-Pathway Somatotropic Synergy: Combines GHRH receptor activation with selective GHRP/GHS-R1a agonist signaling to amplify total growth hormone secretion pulses.
Pulsatile Release Kinetics: Mod GRF 1-29 delivers a short, physiological burst of GH release rather than continuous elevation, mimicking native endocrine rhythms.
High Receptor Selectivity: Ipamorelin selectively triggers GH release without stimulating appetite centers or causing unwanted spikes in serum cortisol or prolactin.
Downstream IGF-1 Axis Activation: Designed to evaluate systemic and localized Insulin-like Growth Factor 1 (IGF-1) upregulation, cellular repair, and protein translation dynamics.
Analytical Purity (≥99%): Independently validated via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee precise concentrations and batch reproducibility.
Primary Applications in Laboratory Research
Pituitary Somatotroph Kinetics: Investigating GHRH-R and GHS-R1a co-stimulation mechanisms and intracellular cAMP/calcium signaling pathways.
Protein Synthesis & Muscle Hypertrophic Pathways: Evaluating Akt/mTOR activation, nitrogen retention, and satellite cell proliferation in cell culture models.
Adipocyte Lipolysis & Metabolic Dynamics: Studying lipid oxidation, fatty acid mobilization, and basal metabolic rate regulation in metabolic models.
Tissue Repair & Extracellular Matrix Regeneration: Researching collagen deposition, connective tissue homeostasis, and bone density signaling pathways.
Product Specifications
Attribute | Specification |
Active Compounds | CJC-1295 No DAC (Mod GRF 1-29) (5 mg) + Ipamorelin (5 mg) |
Net Quantity | 10 mg total per vial |
Form | Lyophilized White Powder |
Purity Standard | ≥99% total peptide purity (HPLC verified) |
Solubility | Soluble in Bacteriostatic Water or Sterile Deionized Water |
Storage & Handling Protocols
Unreconstituted (Lyophilized): Store frozen at or below -20°C in a dry, dark environment protected from heat, light, and humidity.
Reconstituted Solution: Maintain at 2°C – 8°C following dilution with sterile solvent (e.g., Bacteriostatic Water) and utilize within 30 days. Avoid repeated freeze-thaw cycles.
Mandatory Research & Legal Disclaimer
FOR LABORATORY RESEARCH USE ONLY. This blend is provided exclusively for in vitro scientific research, analytical testing, and educational purposes. It is not approved for human or animal consumption, medical treatment, cosmetic application, or commercial drug formulation.